This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

The Ideal Assay for Immune Monitoring

Using ImmunoSpot® Kits, first-time users, from various different laboratories, were able to obtain accurate data with their first-ever attempt to run an ELISPOT assay.
See Publication: (Zhang et al., J. Immunotoxicology, 2009, 6:227).

 

Exquisite Sensitivity

ELISPOT and its variant, FluoroSpot (collectively called ImmunoSpot® Assays) detect in peripheral blood mononuclear cells (PBMC) rare antigen-specific T or B cells via their antigen-driven production of cytokines or antibodies. PBMC sit on a membrane coated with analyte-specific antibody that captures the analyte produced by the individual T or B cells in the immediate surrounding of the secreting cells, before the analyte would be diluted in the culture supernatant, absorbed by receptors of third-party cells, or undergo proteolytic degradation.

ImmunoSpot® Assays are therefore able to measure analyte release by cells with a far greater sensitivity than supernatant-based tests including ELISAs or Bead / Protein Arrays, which rely on testing of samples in the culture medium in which the analyte has been diluted and/or degraded.

ImmunoSpot® Assays are also much more sensitive for detecting rare antigen-specific T and B cells than measurements using flow cytometry even if these occur in frequencies as low as a single analyte-secreting lymphocyte among one million bystander PBMC.

High Specificity

CTL has nearly 20 years of experience in defining and establishing the criteria and software solutions for recognizing antigen-specific T cell cytokine responses. ImmunoSpot® Kits are optimized to distinguish between antigen-specific responses from “background spots” from bystander cells of the innate immune system.

Our colorimetric substrates are chosen for the precision with which they are able to resolve the cytokine signature “spot” produced by each cell, allowing for a quantitative analysis, and size-based “gating” to enumerate antigen-specific responses over bystander cytokine production.

ImmunoSpot® colorimetric substrate development is standardized and optimized for a defined incubation time, further eliminating subjective determinations regarding spot development, while enabling the resolution and discrimination of adjacent and overlapping spots from crowded assay wells.

Unparalleled Reliability

ImmunoSpot® Kits have been standardized and optimized for the highest standards of reliability and reproducibility, which is essential for immune monitoring studies.

Serum-free CTL-Test™ Medium has been formulated to support T cell growth and performance while eliminating the variability inherent in using serum-containing media. Serum has been found to be a major source of variability resulting from uncharacterized immuno-suppressive or stimulatory effects observed in immune monitoring assays. CTL Serum-free Media products are also available for freezing and thawing of cryopreserved PBMC.

ePBMC® Reference Samples are also available for standardization of assay procedures and performance. These cryopreserved PBMC are available in large sample batches, fully HLA types and characterized for antigen responses, making them the perfect assay controls.

Using our ImmunoSpot® Platform, including ELISPOT Kits, Serum-free Media, and ePBMC®, we have demonstrated a dramatically reduced intra- and intra-laboratory variability and high degree of data conformity (Zhang et al., J. Immunotoxicology, 2009, 6:227) between and within labs performing standard ELISPOT assays.

Simplicity

ImmunoSpot® ELISPOT Kits have been developed and standardized to eliminate variability and subjectivity in performance and results. Our reagents and protocols eliminate the need for “prewetting” of the plate membranes with alcohol, and lengthy “blocking” and subsequent washing steps. This eliminates operator variability and error, while also eliminating 14 washing steps.

Our ImmunoSpot® ELISPOT Kits include all buffers and washing solutions, and are available with cell culture medium – further simplifying and standardizing the assay(s).

Plate Scanning and Analysis Services – To accurately image and analyze ELISPOT results requires the use of sophisticated plate scanners and analysis software. CTL has plate scanning and analysis services available and offers a trail version of ImmunoSpot® Software with the purchase of any kit.